207 related articles for article (PubMed ID: 24435119)
1. Surface antigen profiles of leukocytes and melanoma cells in lymph node metastases are associated with survival in AJCC stage III melanoma patients.
Kaufman KL; Mactier S; Armstrong NJ; Mallawaaratchy D; Byrne SN; Haydu LE; Jakrot V; Thompson JF; Mann GJ; Scolyer RA; Christopherson RI
Clin Exp Metastasis; 2014 Apr; 31(4):407-21. PubMed ID: 24435119
[TBL] [Abstract][Full Text] [Related]
2. The number of excised lymph nodes is associated with survival of melanoma patients with lymph node metastasis.
Rossi CR; Mozzillo N; Maurichi A; Pasquali S; Quaglino P; Borgognoni L; Solari N; Piazzalunga D; Mascheroni L; Giudice G; Mocellin S; Patuzzo R; Caracò C; Ribero S; Marone U; Santinami M
Ann Oncol; 2014 Jan; 25(1):240-6. PubMed ID: 24356635
[TBL] [Abstract][Full Text] [Related]
3. An extended antibody microarray for surface profiling metastatic melanoma.
Kaufman KL; Belov L; Huang P; Mactier S; Scolyer RA; Mann GJ; Christopherson RI
J Immunol Methods; 2010 Jun; 358(1-2):23-34. PubMed ID: 20363224
[TBL] [Abstract][Full Text] [Related]
4. Mitotic rate in node-positive stage III melanoma: it might be as important a prognostic factor as node number.
Tas F; Erturk K
Jpn J Clin Oncol; 2021 May; 51(6):873-878. PubMed ID: 33758939
[TBL] [Abstract][Full Text] [Related]
5. Pre-operative ctDNA predicts survival in high-risk stage III cutaneous melanoma patients.
Lee JH; Saw RP; Thompson JF; Lo S; Spillane AJ; Shannon KF; Stretch JR; Howle J; Menzies AM; Carlino MS; Kefford RF; Long GV; Scolyer RA; Rizos H
Ann Oncol; 2019 May; 30(5):815-822. PubMed ID: 30860590
[TBL] [Abstract][Full Text] [Related]
6. Factors predictive of pelvic lymph node involvement and outcomes in melanoma patients with metastatic sentinel lymph node of the groin: A multicentre study.
Mozzillo N; Pasquali S; Santinami M; Testori A; Di Marzo M; Crispo A; Patuzzo R; Verrecchia F; Botti G; Montella M; Rossi CR; Caracò C
Eur J Surg Oncol; 2015 Jul; 41(7):823-9. PubMed ID: 25800935
[TBL] [Abstract][Full Text] [Related]
7. Molecular and biochemical testing in stage III melanoma: multimarker reverse transcriptase-polymerase chain reaction assay of lymph fluid after lymph node dissection and preoperative serum lactate dehydrogenase level.
Nowecki ZI; Rutkowski P; Kulik J; Siedlecki JA; Ruka W
Br J Dermatol; 2008 Sep; 159(3):597-605. PubMed ID: 18616789
[TBL] [Abstract][Full Text] [Related]
8. Tumor mitotic rate added to the equation: melanoma prognostic factors changed? : a single-institution database study on the prognostic value of tumor mitotic rate for sentinel lymph node status and survival of cutaneous melanoma patients.
Speijers MJ; Bastiaannet E; Sloot S; Suurmeijer AJ; Hoekstra HJ
Ann Surg Oncol; 2015 Sep; 22(9):2978-87. PubMed ID: 25605514
[TBL] [Abstract][Full Text] [Related]
9. Prognostic factors in melanoma patients with tumor-negative sentinel lymph nodes.
Egger ME; Bhutiani N; Farmer RW; Stromberg AJ; Martin RC; Quillo AR; McMasters KM; Scoggins CR
Surgery; 2016 May; 159(5):1412-21. PubMed ID: 26775577
[TBL] [Abstract][Full Text] [Related]
10. Lymph node ratio has impact on relapse and outcome in patients with stage III melanoma.
Tas F; Erturk K
Int J Clin Oncol; 2019 Jun; 24(6):721-726. PubMed ID: 30788673
[TBL] [Abstract][Full Text] [Related]
11. Lymph node ratio is an important and independent prognostic factor for patients with stage III melanoma.
Berger AC; Fierro M; Kairys JC; Berd D; Sato T; Andrel J; Hyslop T; Mastrangelo MJ
J Surg Oncol; 2012 Jan; 105(1):15-20. PubMed ID: 21815149
[TBL] [Abstract][Full Text] [Related]
12. Lymph-Node Ratio in Patients with Cutaneous Melanoma: A Multi-Institution Prognostic Study.
Sandro P; Andrea M; Nicola M; Simone M; Giuseppe M; Lorenzo B; Nicola S; Dario P; Luigi M; Giuseppe G; Roberto P; Corrado C; Simone R; Ugo M; Mario S; Riccardo RC
Ann Surg Oncol; 2015 Jul; 22(7):2127-34. PubMed ID: 25316489
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant irradiation for axillary metastases from malignant melanoma.
Ballo MT; Strom EA; Zagars GK; Bedikian AY; Prieto VG; Mansfield PF; Lee JE; Gershenwald JE; Ross MI
Int J Radiat Oncol Biol Phys; 2002 Mar; 52(4):964-72. PubMed ID: 11958890
[TBL] [Abstract][Full Text] [Related]
14. N-ratio: a novel independent prognostic factor for patients with stage-III cutaneous melanoma.
Rossi CR; Mocellin S; Pasquali S; Pilati P; Nitti D
Ann Surg Oncol; 2008 Jan; 15(1):310-5. PubMed ID: 17987346
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of BRAF(V⁶⁰⁰) mutations in melanoma patients after resection of metastatic lymph nodes.
Moreau S; Saiag P; Aegerter P; Bosset D; Longvert C; Hélias-Rodzewicz Z; Marin C; Peschaud F; Chagnon S; Zimmermann U; Clerici T; Emile JF
Ann Surg Oncol; 2012 Dec; 19(13):4314-21. PubMed ID: 22772867
[TBL] [Abstract][Full Text] [Related]
16. Clinical and pathologic factors associated with distant metastasis and survival in patients with thin primary cutaneous melanoma.
Murali R; Haydu LE; Long GV; Quinn MJ; Saw RP; Shannon K; Spillane AJ; Stretch JR; Kefford RF; Thompson JF; Scolyer RA
Ann Surg Oncol; 2012 Jun; 19(6):1782-9. PubMed ID: 22350600
[TBL] [Abstract][Full Text] [Related]
17. Palliative radiotherapy for recurrent and metastatic malignant melanoma: prognostic factors for tumor response and long-term outcome: a 20-year experience.
Seegenschmiedt MH; Keilholz L; Altendorf-Hofmann A; Urban A; Schell H; Hohenberger W; Sauer R
Int J Radiat Oncol Biol Phys; 1999 Jun; 44(3):607-18. PubMed ID: 10348291
[TBL] [Abstract][Full Text] [Related]
18. Extranodal Spread is Associated with Recurrence and Poor Survival in Stage III Cutaneous Melanoma Patients.
Crookes TR; Scolyer RA; Lo S; Drummond M; Spillane AJ
Ann Surg Oncol; 2017 May; 24(5):1378-1385. PubMed ID: 28130620
[TBL] [Abstract][Full Text] [Related]
19. The role of sentinel lymph node biopsy in patients with local recurrence or in-transit metastasis of melanoma.
Gipponi M; Solari N; Giovinazzo D; Queirolo P; Bertoglio S; Villa G; Gualco M; Bleidl D; Cafiero F
Anticancer Res; 2014 Jun; 34(6):3197-203. PubMed ID: 24922694
[TBL] [Abstract][Full Text] [Related]
20. Prognostic factors in 1,521 melanoma patients with distant metastases.
Barth A; Wanek LA; Morton DL
J Am Coll Surg; 1995 Sep; 181(3):193-201. PubMed ID: 7670677
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
